EQQJ:LSE:LSE-Invesco NASDAQ Next Generation 100 UCITS ETF Acc (USD)

ETF | Others |

Last Closing

USD 32.07

Change

0.00 (0.00)%

Market Cap

N/A

Volume

8.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-11.45 (-6.28%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.39 (-2.35%)

USD 640.06B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.15 (-1.21%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

-1.88 (-1.97%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-3.70 (-5.21%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-0.61 (-2.23%)

USD 259.48B
0QZO:LSE 0QZO

-2.70 (-3.17%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-4.90 (-3.71%)

USD 202.26B
0R24:LSE Intel Corp.

-1.60 (-7.74%)

USD 196.14B

ETFs Containing EQQJ:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -14.41% 17% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -14.41% 17% F 25% F
Trailing 12 Months  
Capital Gain -5.90% 26% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.90% 25% F 39% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.61% 55% F 61% D-
Dividend Return 7.61% 54% F 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.16% 70% C- 83% B
Risk Adjusted Return 82.99% 80% B- 87% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike